The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CRITICS-II: A multicenter randomized phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer.
 
Marcel Verheij
No Relationships to Disclose
 
Nicole van Grieken
Consulting or Advisory Role - Amgen (Inst); BMS (Inst); Gilead Sciences (Inst); Merck (Inst)
Speakers' Bureau - Amgen (Inst); AstraZeneca (Inst); BMS (Inst); MSD (Inst)
Research Funding - Amgen (Inst)
 
Astrid Slagter
No Relationships to Disclose
 
Romy van Amelsfoort
No Relationships to Disclose
 
Shermarke Hassan
No Relationships to Disclose
 
Evelien Schouten
No Relationships to Disclose
 
Fabienne Warmerdam
No Relationships to Disclose
 
Grard Nieuwenhuijzen
Research Funding - Medtronic
 
Henk Hartgrink
No Relationships to Disclose
 
Marco Polee
No Relationships to Disclose
 
Laurens Beerepoot
Consulting or Advisory Role - Bristol Myers Squibb Foundation; SERVIER
 
Ronald Hoekstra
No Relationships to Disclose
 
Richard van Hillegersberg
Consulting or Advisory Role - Intuitive Surgical; Medtronic; Olympus
Research Funding - Intuitive Surgical
 
Eline Boon
No Relationships to Disclose
 
Maartje Los
No Relationships to Disclose
 
Theo Van Voorthuizen
Travel, Accommodations, Expenses - Ipsen
 
Annelie Vulink
No Relationships to Disclose
 
Edwin Jansen
No Relationships to Disclose
 
Johanna van Sandick
No Relationships to Disclose
 
Hanneke Van Laarhoven
Consulting or Advisory Role - Amgen (Inst); Amphera (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Daiichi (Inst); MSD Oncology (Inst); MyeoloidTx (Inst)
Speakers' Bureau - AstraZeneca (Inst); BMS (Inst); CongressCare (Inst); Daiichy Sankyo (Inst); MedTalks (Inst); Travel Congress Management (Inst); Uitgeverij Jaap (Inst)
Research Funding - Amgen (Inst); Auristone; BMS (Inst); Incyte (Inst); Merck KGaA (Inst); ORCA Therapeutics (Inst); Servier (Inst)
Travel, Accommodations, Expenses - AstraZeneca